Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.

Malte KircherSandra IhneJoachim BrumbergCaroline MorbachStefan KnopK Martin KortümStefan StörkAndreas K BuckTheresa ReiterWolfgang R BauerConstantin Lapa

Published in: European journal of nuclear medicine and molecular imaging (2019)

Imaging of cardiac amyloidosis (CA) with 18F-florbetaben-PET/CT is feasible and might be useful in differentiating CA subtypes.

Keyphrases

pet ct
left ventricular
positron emission tomography
contrast enhanced
high resolution
computed tomography
heart failure
pulmonary hypertension
photodynamic therapy
diffusion weighted imaging
sensitive detection
real time pcr